Medtronic (NYSE:MDT) hit a new 52-week high Tuesday as it is currently trading at $41.84, above its previous 52-week high of $41.79 with 861,187 shares traded as of 11 a.m. ET. Average volume has been 4.4 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model NEW YORK ( TheStreet) -- Medtronic (NYSE: MDT) hit a new 52-week high Tuesday as it is currently trading at $41.84, above its previous 52-week high of $41.79 with 861,187 shares traded as of 11 a.m. ET. Average volume has been 4.4 million shares over the past 30 days. Medtronic has a market cap of $42.45 billion and is part of the health care sector and health services industry. Shares are up 8.8% year to date as of the close of trading on Monday. Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company has a P/E ratio of 12.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, increase in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Medtronic Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.